Today is World Alzheimer’s Day. There are more than 55 million people globally with Alzheimer’s disease. Fifty-five million that are struggling to remember. With advanced technology, there has been new hope in the fight against a devastating disease. Enter AI, a technology that famously struggles to forget. What if it could remember hundreds of thousands of MRI scans and blood tests? And then, apply that knowledge to how we comprehend, diagnose, and treat one of the leading killers in the United States?
That’s exactly the case with research being done in the Keck School of Medicine of USC and the USC Viterbi School of Engineering, led by Paul Thompson, the associate director of the USC Mark and Mary Stevens Neuroimaging and Informatics Institute and a professor in the Keck School of Medicine.The promise of AI detection and the power of collaboration have been game changers for AI and AD. The Artificial Intelligence for Alzheimer’s Disease Consortium (AI for AD), spearheaded by Thompson, is leading this transformative journey. Funded by the National Institutes of Health (NIH) with an $18 million grant, the project spans 12 research sites across the U.S., with USC as the lead site.
Read more about this collaborative project in this article written by Omar Lewis: